ASGE Annual Postgraduate Course: Leveraging New Advances to Improve Patient Outcomes (On-demand) | May 2024-Optimal Treatment & Disease Monitoring in EoE

Video Transcription

Video Summary

Dr. Crystal Lynch, director of the Saphage Lin Swelling Center at the University of Pennsylvania, discussed optimal treatment and disease monitoring for EOE in the video. EOE is an immune-mediated condition affecting the esophagus, leading to eosinophilic infiltrate and chronic inflammation. Various treatment options were covered, including PPIs, topical steroids, and the newly FDA-approved budesonide oral suspension. Additionally, the use of biologics like dupilumab was highlighted. Dietary therapy, such as elimination diets, and esophageal dilation were also discussed for managing EOE. Dr. Lynch emphasized the need for maintenance therapy, regular follow-up, and shared decision-making to improve symptoms, control inflammation, and prevent complications. Future advancements in EOE treatment were also mentioned.

Asset Subtitle

Kristle Lee Lynch, MD

Meta Tag

Concept Eosinophilic Esophagitis

Concept Symptom Relief

Concept Inflammation

Concept Fibrostenotic Complications

Concept Proton Pump Inhibitor

Keywords

EOE

immune-mediated condition

treatment options

biologics

dietary therapy

Eosinophilic Esophagitis

Symptom Relief

Inflammation

Fibrostenotic Complications

Proton Pump Inhibitor